Global Vaccines Market Growth 2025-2032 | Segmentation, Demand Drivers & Top Players Analysis - GSK plc., Merck & Co., Inc., Pfizer Inc., CSL, EMERGENT, Johnson & Johnson Services, Inc

The Global Vaccines Market reached US$ 77.01 billion in 2024 and is expected to reach US$ 108.82 billion by 2032, growing at a CAGR of 3.9% during the forecast period 2025-2032.

Vaccines Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM Intelligence, we're committed to turning complex market landscapes into clear, actionable strategies so you can stay competitive, grow confidently, and seize the right opportunities in a rapidly changing world.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access): https://datamintelligence.com/download-sample/vaccines-market?kb

Vaccines are biological preparations that provide immunity to a specific disease, usually containing weakened or inactivated pathogens, or their components, to stimulate the body's immune response without causing illness.

List of the Key Players in the Vaccines Market:

GSK plc., Merck & Co., Inc., Pfizer Inc., CSL, EMERGENT, Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Bharat Biotech and Serum Institute of India Pvt. Ltd. among others.

Industry Development:

In October 2024, the Ministry of Health of Cambodia launched a nationwide measles-rubella supplementary immunization campaign, targeting over 1.5 million children aged 9 to 59 months across all 25 provinces. The initiative is supported by Gavi, the Vaccine Alliance, with technical backing from WHO, UNICEF, and the Clinton Health Access Initiative (CHAI).

In September 2024, Zambia initiated a large-scale measles vaccination drive aiming to reach four million children between nine months and five years of age. This effort comes in response to declining immunization coverage during the COVID-19 pandemic.

In January 2024, the NHS in England rolled out a catch-up campaign for missed MMR (measles, mumps, and rubella) vaccinations. Millions of parents and caregivers are being urged to ensure their children are protected, as the country experiences a concerning rise in measles cases.

In June 2024, Moderna, Inc. reported positive results from its Phase 3 trial of mRNA-1083, an experimental combination vaccine for influenza and COVID-19. The vaccine successfully met its primary endpoints, producing stronger immune responses than the currently licensed comparator vaccines used in the study.

Research Process:

Both primary and secondary data sources have been used in the global Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/vaccines-market?kb

Segment Covered in the Vaccines Market:

By Type: Conjugate Vaccines, Inactivated Vaccines, Live-attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Others

By Category: Monovalent Vaccines, Bivalent Vaccines, Multivalent Vaccines

By Disease Indication: Chickenpox, Cholera, Diphtheria, Influenza, Hepatitis, Measles, Mumps, Polio, Rabies, Others

By Route of Administration: Intramuscular, Subcutaneous, Intranasal, Others

By End User: Community Hospitals, Hospitals, Specialty Centers, Clinics, Others

Regional Analysis for Vaccines Market:

The regional analysis of the Vaccines Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/vaccines-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Vaccines market?

➠ Who are the leading manufacturers in the global Vaccines industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Vaccines industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Vaccines market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.